Antitumor agents: development of highly potent glycosidic duocarmycin analogues for selective cancer therapy

Angew Chem Int Ed Engl. 2006 Oct 6;45(39):6574-7. doi: 10.1002/anie.200600936.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkylating Agents / chemical synthesis*
  • Alkylating Agents / therapeutic use*
  • Antibodies / therapeutic use
  • Cell Line, Tumor
  • Drug Delivery Systems
  • Duocarmycins
  • Humans
  • Indoles / chemical synthesis*
  • Indoles / therapeutic use*
  • Neoplasms / drug therapy*
  • Prodrugs / therapeutic use
  • Pyrroles / chemical synthesis
  • Pyrroles / therapeutic use
  • Streptomyces / chemistry
  • Tumor Stem Cell Assay

Substances

  • Alkylating Agents
  • Antibodies
  • Duocarmycins
  • Indoles
  • Prodrugs
  • Pyrroles
  • duocarmycin SA